Miriam Ec Hancock

Title: The Innovative Contributions of Miriam Ec Hancock

Introduction

Miriam Ec Hancock is a notable inventor based in Oakland, CA, who has made significant strides in the field of cancer therapy. His work focuses on developing novel drug combinations that target tumor cells effectively. With a patent portfolio that includes innovative approaches to cancer treatment, Hancock's contributions are noteworthy in the medical community.

Latest Patents

Hancock holds a patent for the "Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy." This invention is directed toward novel synergistic combinations of ligand-mimicking agents specific to the c-erbB-2 protein and anti-neoplastic drugs or agents. These combinations can be used to treat a mammalian host, usually a human, suspected of having cancer or tumor cells. The drug combinations are cytotoxic to tumor cells and comprise an anti-neoplastic agent and a molecule that binds the tumor cells, inducing an increase in the phosphorylation of the c-erbB-2 protein. This combination is particularly effective for inhibiting the growth of breast and ovarian tumor cells.

Career Highlights

Miriam Ec Hancock has worked with Berlex Laboratories, Inc., where he has contributed to the development of innovative cancer therapies. His research and inventions have the potential to improve treatment outcomes for patients suffering from various forms of cancer.

Collaborations

Hancock has collaborated with notable colleagues in the field, including Laura K Shawver and John W Brandis. These partnerships have likely enhanced the scope and impact of his research.

Conclusion

Miriam Ec Hancock's innovative work in cancer therapy exemplifies the importance of combining scientific research with practical applications. His patent on ligand-mimicking agents and anti-neoplastic drugs represents a significant advancement in the fight against cancer.